GSE130437 palbociclib 0 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE130437_palbociclib_0_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE130437_palbociclib_0_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE130437_palbociclib_0_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE130437_palbociclib_0_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

DPPA2 upstream binding RNA

Gene

urothelial cancer associated 1

Gene

long intergenic non-protein coding RNA 973

Gene

long intergenic non-protein coding RNA 1234

Gene

AFAP1 antisense RNA 1

Gene

fatty acyl-CoA reductase 2 pseudogene 2

Gene

RAB6C antisense RNA 1

Gene

XXYLT1 antisense RNA 2

Gene

long intergenic non-protein coding RNA 2212

Gene

HLA complex group 15

  • Gene

    DPPA2 upstream binding RNA


  • Gene

    urothelial cancer associated 1


  • Gene

    long intergenic non-protein coding RNA 973


  • Gene

    long intergenic non-protein coding RNA 1234


  • Gene

    AFAP1 antisense RNA 1


  • Gene

    fatty acyl-CoA reductase 2 pseudogene 2


  • Gene

    RAB6C antisense RNA 1


  • Gene

    XXYLT1 antisense RNA 2


  • Gene

    long intergenic non-protein coding RNA 2212


  • Gene

    HLA complex group 15

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.